1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant capecitabine 'noninferior' to 5-FU in rectal Ca trial: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • p53 expression in node-positive breast cancer patients: Results from the Cancer and Leukemia Group B 9344 trial (159905)
    Journal Article

    Lara, J. F.; Thor, A. D.; Dressler, L. G.; Broadwater, G.; Bleiweiss, I. J.; Edgerton, S.; Cowan, D.; Goldstein, L. J.; Martino, S.; Ingle, J. N.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial
    Journal Article

    Chochinov, H. M.; Kristjanson, L. J.; Breitbart, W.; McClement, S.; Hack, T. F.; Hassard, T.; Harlos, M.
    Lancet Oncology (2011)

    Fulltext@MSK | Save
  • Prolotherapy versus corticosteroid injections for the treatment of lateral epicondylosis: A randomized controlled trial
    Journal Article

    Carayannopoulos, A.; Borg-Stein, J.; Sokolof, J.; Meleger, A.; Rosenberg, D.
    PM&R (2011)

    Fulltext@MSK | Save
  • The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies
    Journal Article

    Balagula, Y.; Rosen, S. T.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2011)

    Fulltext@MSK | Save
  • Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
    Journal Article

    Wefel, J. S.; Cloughesy, T.; Zazzali, J. L.; Zheng, M.; Prados, M.; Wen, P. Y.; Mikkelsen, T.; Schiff, D.; Abrey, L. E.; Alfred Yung, W. K.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
    Journal Article

    Shapiro, C. L.; Halabi, S.; Hars, V.; Archer, L.; Weckstein, D.; Kirshner, J.; Sikov, W.; Winer, E.; Burstein, H. J.; Hudis, C.; more...
    European Journal of Cancer (2011)

    Fulltext@MSK | Save
  • Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer
    Journal Article

    Seidman, A. D.; Brufsky, A.; Ansari, R. H.; Hart, L. L.; Stein, R. S.; Schwartzberg, L. S.; Stewart, J. F.; Russell, C. A.; Chen, S. C.; Fein, L. E.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D.; Liu, G.; Carducci, M. A.; Eisenberger, M. A.; Anand, A.; Morris, M. J.; Slovin, S. F.; Sasaki, Y.; Takahashi, S.; Ozono, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • A randomized controlled trial of skin care protocols for facial resurfacing: Lessons learned from the plastic surgery educational foundation's skin products assessment research study
    Journal Article

    Pannucci, C. J.; Reavey, P. L.; Kaweski, S.; Hamill, J. B.; Hume, K. M.; Wilkins, E. G.; Pusic, A. L.
    Plastic and Reconstructive Surgery (2011)

    Fulltext@MSK | Save